COL18A1 and Thrombocytopenia: Grade 4 adverse reactions occurred in only 1 patient of rh‐endostatin 7d group who developed thrombocytopenia after treatment, and platelet count gradually returned to normal after treatment of megakaryocyte (recombinant interleukin 11).